Soleno Therapeutics, Inc. Profile Avatar - Palmy Investing

Soleno Therapeutics, Inc.

Soleno Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutics for the treatment of rare diseases. Its lead candidate is Diazoxide Choline Controlled-Release, a once-daily ora…

Biotechnology
US, Redwood City [HQ]
Growth Rates · Payout · Yield

Dividends Over Time

  • Records
  • Forecasts [Soon]
Growth Rates
% YoY
% 3Yr
% 5Yr
% 10Yr
Key Metrics
- -% TTM Yield
- - Average Days Gap
Series
% - - Yield
0.00% Payout Ratio
Download
Cash Amount Pay Date
Download
Cash Amount Pay Date
End of SLNO's Analysis
CIK: 1484565 CUSIP: 834203200 ISIN: US8342033094 LEI: - UEI: -
Secondary Listings
SLNO has no secondary listings inside our databases.